Several other brokerages have also recently issued reports on JMAT. Liberum Capital dropped their price target on Johnson Matthey from GBX 4,400 ($57.49) to GBX 3,500 ($45.73) and set a buy rating on the stock in a research report on Wednesday, November 27th. JPMorgan Chase & Co. downgraded Johnson Matthey to an underweight rating and reduced their price objective for the company from GBX 3,400 ($44.43) to GBX 2,850 ($37.24) in a research note on Thursday, November 28th. Berenberg Bank decreased their price objective on Johnson Matthey from GBX 3,750 ($49.00) to GBX 3,600 ($47.04) and set a buy rating for the company in a research report on Monday, November 25th. Barclays lowered their target price on Johnson Matthey from GBX 3,790 ($49.52) to GBX 3,330 ($43.51) and set an equal weight rating on the stock in a research note on Wednesday, November 27th. Finally, Deutsche Bank dropped their target price on Johnson Matthey from GBX 3,700 ($48.35) to GBX 3,600 ($47.04) and set a buy rating on the stock in a report on Friday, November 22nd. Two investment analysts have rated the stock with a sell rating, one has assigned a hold rating and six have issued a buy rating to the stock. Johnson Matthey presently has a consensus rating of Hold and an average target price of GBX 3,403.75 ($44.48).
Shares of JMAT opened at GBX 2,818 ($36.82) on Tuesday. Johnson Matthey has a fifty-two week low of GBX 2,574 ($33.63) and a fifty-two week high of GBX 3,475 ($45.41). The company has a market capitalization of $5.45 billion and a price-to-earnings ratio of 14.08. The firm has a 50-day simple moving average of GBX 3,068.88 and a 200-day simple moving average of GBX 3,081.90. The company has a debt-to-equity ratio of 59.25, a quick ratio of 0.90 and a current ratio of 1.54.
In other Johnson Matthey news, insider Robert MacLeod purchased 5,250 shares of the firm’s stock in a transaction that occurred on Monday, November 25th. The shares were purchased at an average cost of GBX 2,842 ($37.14) per share, for a total transaction of £149,205 ($194,962.76). Also, insider Anna Manz acquired 12 shares of the company’s stock in a transaction that occurred on Wednesday, September 18th. The shares were acquired at an average cost of GBX 3,136 ($40.98) per share, for a total transaction of £376.32 ($491.73). Over the last quarter, insiders have bought 7,786 shares of company stock worth $22,180,092.
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.